Moreover, the immunohistochemical studies of TRX1 revealed that only cytosolic localization was observed in the hippocampus CA1 of AD patients, whereas TRX1 in the control patients was observed in the nucleus, with no difference in the expressing levels between control and AD patients [63]. Here, TXN is linked to Alzheimer disease.